Frazier Life Sciences Management, L.P. Savara Inc Transaction History
Frazier Life Sciences Management, L.P.
- $1.7 Billion
- Q2 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Savara Inc stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 8,157,385 shares of SVRA stock, worth $34.3 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
8,157,385
Previous 4,000,000
103.93%
Holding current value
$34.3 Million
Previous $19.9 Million
65.03%
% of portfolio
1.94%
Previous 1.05%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
145Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$103 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$61.2 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$51.9 Million7.46% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$33.7 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.02MShares$29.5 Million0.01% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $479M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.